COVID-19
Mar 6, 2023
The SARS-COV-2 prevalence study assessed the prevalence of active and recovered COVID infections in the Bronx and Harlem communities. https://clinicaltrials.gov/ct2/show/NCT04658121 The COMPASS...
Feb 19, 2023
ICAP expanded support for JOOTRH through strengthening the existing triage system with appropriate referral and care of confirmed COVID-19 cases, either in self-isolation at home or in JOOTRH’s isolation unit. ICAP also provided education materials and locally sewn...
Jan 18, 2023
Primary objective 1: To identify serologic reactivities that differentiate SARS-CoV-2 infection from vaccination. Primary objective 2: To develop and formally qualify a suite of immunologic assays and reference reagents that permit detailed interrogations of the...
Jan 14, 2023
Characterizing SARS-CoV-2-specific immunity in convalescent individuals Clinical Trials
Jan 2, 2023
Supported by the U.S. Centers for Disease Control and Prevention’s (CDC) Emergency International Task Force (ITF) funds, ICAP provided technical expertise in infection prevention and control, surveillance, procurement, and clinical services for the Ministry of...